These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9137213)

  • 1. Heart rate is a marker of amiodarone mortality reduction in severe heart failure. The GESICA-GEMA Investigators. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina-Grupo de Estudios Multicéntricos en Argentina.
    Nul DR; Doval HC; Grancelli HO; Varini SD; Soifer S; Perrone SV; Prieto N; Scapin O
    J Am Coll Cardiol; 1997 May; 29(6):1199-205. PubMed ID: 9137213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA).
    Doval HC; Nul DR; Grancelli HO; Perrone SV; Bortman GR; Curiel R
    Lancet; 1994 Aug; 344(8921):493-8. PubMed ID: 7914611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Class III antiarrhythmic agents in cardiac failure: lessons from clinical trials with a focus on the Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA).
    Doval HC
    Am J Cardiol; 1999 Nov; 84(9A):109R-114R. PubMed ID: 10568669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone and "primary" prevention of sudden death: critical review of a decade of clinical trials.
    Farré J; Romero J; Rubio JM; Ayala R; Castro-Dorticós J
    Am J Cardiol; 1999 Mar; 83(5B):55D-63D. PubMed ID: 10089841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone therapy in chronic heart failure and myocardial infarction: a review of the mortality trials with special attention to STAT-CHF and the GESICA trials. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina.
    Pinto JV; Ramani K; Neelagaru S; Kown M; Gheorghiade M
    Prog Cardiovasc Dis; 1997; 40(1):85-93. PubMed ID: 9247558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone -- waxed and waned and waxed again.
    Doggrell SA
    Expert Opin Pharmacother; 2001 Nov; 2(11):1877-90. PubMed ID: 11825323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsustained ventricular tachycardia in severe heart failure. Independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators.
    Doval HC; Nul DR; Grancelli HO; Varini SD; Soifer S; Corrado G; Dubner S; Scapin O; Perrone SV
    Circulation; 1996 Dec; 94(12):3198-203. PubMed ID: 8989129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amiodarone: clinical trials.
    Naccarelli GV; Wolbrette DL; Patel HM; Luck JC
    Curr Opin Cardiol; 2000 Jan; 15(1):64-72. PubMed ID: 10666663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of a standardized titration protocol with carvedilol in heart failure: safety, tolerability, and efficacy-a report from the GESICA registry.
    Nul D; Zambrano C; Diaz A; Ferrante D; Varini S; Soifer S; Grancelli H; Doval H;
    Cardiovasc Drugs Ther; 2005 Mar; 19(2):125-34. PubMed ID: 16025231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
    Fishbein DP; Hellkamp AS; Mark DB; Walsh MN; Poole JE; Anderson J; Johnson G; Lee KL; Bardy GH;
    J Am Coll Cardiol; 2014 Jun; 63(23):2560-2568. PubMed ID: 24727258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators.
    Massie BM; Fisher SG; Radford M; Deedwania PC; Singh BN; Fletcher RD; Singh SN
    Circulation; 1996 Jun; 93(12):2128-34. PubMed ID: 8925581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
    Bardy GH; Lee KL; Mark DB; Poole JE; Packer DL; Boineau R; Domanski M; Troutman C; Anderson J; Johnson G; McNulty SE; Clapp-Channing N; Davidson-Ray LD; Fraulo ES; Fishbein DP; Luceri RM; Ip JH;
    N Engl J Med; 2005 Jan; 352(3):225-37. PubMed ID: 15659722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidity and mortality following early administration of amiodarone in acute myocardial infarction. GEMICA study investigators, GEMA Group, Buenos Aires, Argentina. Grupo de Estudios Multicéntricos en Argentina.
    Elizari MV; Martínez JM; Belziti C; Ciruzzi M; Pérez de la Hoz R; Sinisi A; Carbajales J; Scapín O; Garguichevich J; Girotti L; Cagide A
    Eur Heart J; 2000 Feb; 21(3):198-205. PubMed ID: 10639301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators.
    Lancet; 1997 Nov; 350(9089):1417-24. PubMed ID: 9371164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of amiodarone on the circadian pattern of sudden cardiac death (Department of Veterans Affairs Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy).
    Behrens S; Ney G; Fisher SG; Fletcher RD; Franz MR; Singh SN
    Am J Cardiol; 1997 Jul; 80(1):45-8. PubMed ID: 9205018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone in congestive heart failure: unravelling the GESICA and CHF-STAT differences.
    Hammill SC; Packer DL
    Heart; 1996 Jan; 75(1):6-7. PubMed ID: 8624874
    [No Abstract]   [Full Text] [Related]  

  • 17. Amiodarone attenuates the proarrhythmic effects of dobutamine in patients with advanced congestive heart failure.
    Tsagalou EP; Gounopoulos P; Terrovitis JV; Drakos SG; Katsaros FT; Kaldara EE; Alexopoulos GP; Anastasiou-Nana MI
    Hellenic J Cardiol; 2009; 50(3):193-8. PubMed ID: 19465360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
    Singh SN; Fletcher RD; Fisher SG; Singh BN; Lewis HD; Deedwania PC; Massie BM; Colling C; Lazzeri D
    N Engl J Med; 1995 Jul; 333(2):77-82. PubMed ID: 7539890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac death.
    Au-Yeung WT; Reinhall PG; Poole JE; Anderson J; Johnson G; Fletcher RD; Moore HJ; Mark DB; Lee KL; Bardy GH
    Heart Rhythm; 2015 Oct; 12(10):2058-66. PubMed ID: 26096609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose amiodarone in severe chronic heart failure.
    Biswas A; Dey SK; Banerjee AK; Roy S; Biswas PK; Chowdhury GK; Khan AK; Mitra KK; Chatterjee SS; Maity AK
    Indian Heart J; 1996; 48(4):361-4. PubMed ID: 8908821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.